Your browser doesn't support javascript.
loading
Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study.
Fukuda, Tomoo; Yamagami, Keiko; Kawahata, Kimito; Suzuki, Yuzo; Sasaki, Yoshihiro; Miyagi, Takashi; Jacobs, Iris; Lawo, John-Philip; Glassman, Fiona; Akama, Hideto; Hide, Michihiro; Ohsawa, Isao.
Affiliation
  • Fukuda T; Department of Dermatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan. Electronic address: fukuda@saitama-med.ac.jp.
  • Yamagami K; Department of Internal Medicine, Osaka City General Hospital, Osaka, Japan.
  • Kawahata K; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Suzuki Y; Department of Respiratory Medicine, Clover Hospital, Kanagawa, Japan.
  • Sasaki Y; Department of Gastroenterology, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
  • Miyagi T; Department of Hematology, Heart-Life Hospital, Okinawa, Japan.
  • Jacobs I; CSL Behring, King of Prussia, PA, USA.
  • Lawo JP; CSL Behring Innovation GmbH, Marburg, Germany.
  • Glassman F; CSL Behring, King of Prussia, PA, USA.
  • Akama H; CSL Behring Japan, Tokyo, Japan.
  • Hide M; Department of Dermatology, Hiroshima University, Hiroshima, Japan; Department of Dermatology, Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Ohsawa I; Department of Nephrology, Saiyu Soka Hospital, Saitama, Japan.
Allergol Int ; 72(3): 451-457, 2023 Jul.
Article in En | MEDLINE | ID: mdl-36858856

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complement C1 Inhibitor Protein / Angioedemas, Hereditary Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Journal: Allergol Int Journal subject: ALERGIA E IMUNOLOGIA Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complement C1 Inhibitor Protein / Angioedemas, Hereditary Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Journal: Allergol Int Journal subject: ALERGIA E IMUNOLOGIA Year: 2023 Type: Article